Becker's Healthcare July 18, 2025
As health systems face mounting pressure to cut costs without compromising care, a growing number are turning to AI in the mid-revenue cycle. Technology investments have to do more than promise value, however — they must prove it.
A new 2025 KLAS Second Look Report suggests that Xsolis’ Dragonfly, the next generation of the company’s AI-driven platform that improves medical necessity decision-making, is hitting the mark, delivering measurable outcomes to hospitals and health systems. In anonymized client interviews with KLAS, Dragonfly users report improved denial rates, reduced length of stay (LOS), and rapidly achieved return on investment — all while enhancing payer-provider collaboration.
Denials: A $20 Billion Drain
Preventable denials aren’t just an administrative headache — they’re a debilitating financial...







